GSK is cutting staff, and a lot of it, reports Derek Lowe at In the Pipeline. "I'm hearing that the smallest cuts are around 40% of the entire research staff at the various sites,"  he writes. For those who have never been through a layoff, or are new to industry, Lowe wonders how much the "grass is greener" mentality will play into departing scientists' ideas of why they were let go.